SARS‐CoV‐2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release
mLife · 2026-06 · 5 (3) · 339-354
DOI: 10.1002/mlf2.70065 ↗Kurz gefasst
Fachartikel in der Zeitschrift mLife, online erschienen am 26.06.2026. Verfasst von Fujun Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology Chinese A…. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The mechanism of SARS‐CoV‐2 egress predominantly governs the quantity and quality of progeny viruses, thereby significantly contributing to viral pathogenicity. However, the key factors influencing viral egress remain largely unclear. In this study, using transcription‐ and replication‐competent SARS‐CoV‐2 virus‐like‐particle (SARS‐CoV‐2 trVLP), electron microscopy, drug inhibition assays, and cellular pH‐sensitive fluorescent probes, we demonstrate that increased lysosomal exocytosis efficiency and lysosome deacidification play a pivotal role in facilitating SARS‐CoV‐2 egress. Specifically, SARS‐CoV‐2 may use multiple egress pathways, with lysosomal exocytosis as the primary mechanism and the biosynthetic secretory pathway as a less efficient route. Viral infection enhances lysosomal exocytosis via the ORF3a protein, thus facilitating viral release. SARS‐CoV‐2 infection also induces lysosome deacidification; moreover, treatment with bafilomycin A1, which induces lysosome deacidification, further enhances viral egress. Furthermore, we systematically investigate how viral proteins affect lysosomal pH and enzymatic activities. Our findings reveal that ORF3a and E proteins induce lysosome deacidification and diminish lysosomal enzyme activities, probably protecting progeny viruses from premature cleavage and degradation. This study provides mechanistic insight into how SARS‐CoV‐2 promotes lysosomal exocytosis and triggers lysosome deacidification for viral release.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences Shenzhen China.
- State Key Laboratory of Biomacromolecules, Institute of Biophysics Chinese Academy of Sciences Beijing China.
- School of Medicine Tsinghua University Beijing China.
- Faculty of Synthetic Biology Shenzhen University of Advanced Technology Shenzhen China.
ORCID-Profile: Xian-En Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qin, F., Yan, C., Liu, Z., Wang, D., Zhong, H., Ding, Q., Chen, M., & Zhang, X. E. (2026). SARS‐CoV‐2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release. mLife, 5(3), 339-354. https://doi.org/10.1002/mlf2.70065
Vancouver
Qin F, Yan C, Liu Z, Wang D, Zhong H, Ding Q, et al. SARS‐CoV‐2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release. mLife. 2026;5(3):339-354. doi:10.1002/mlf2.70065
BibTeX
@article{Qin2026,
author = {Qin, Fujun and Yan, Chuang and Liu, Zizheng and Wang, Dianbing and Zhong, Huimin and Ding, Qiang and Chen, Minghai and Zhang, Xian-En},
title = {SARS‐CoV‐2 enhances lysosomal exocytosis and deacidifies lysosomes to facilitate viral release},
journal = {mLife},
year = {2026},
volume = {5},
number = {3},
pages = {339--354},
doi = {10.1002/mlf2.70065}
}
EUVIMED